Areas of Expertise
Neuroscience • Medicine • Exponentials • Biotech
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as Faculty Chair for Medicine at Singularity University since SU’s inception, and founded and is chair of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children’s Hospital, and fellowships in hematology, oncology and bone marrow transplantation at Stanford. He has multiple patents on medical device, immunology and stem cell related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California, San Francisco.
Daniel was selected as a fellow of the inaugural 2016 class of the Aspen Institute Health Innovators Fellowship and is a member of the Aspen Global Leadership Network.
Daniel’s academic research has focused on: stem cell biology and regenerative medicine, stem cell derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. Clinical work focuses on: bone marrow / hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell based regenerative medicine, including marrow derived stem cell harvesting, processing and delivery. He also implemented the first text-paging system at Stanford Hospital. Dr. Kraft recently founded IntelliMedicine, focused on enabling connected, data driven, and integrated personalized medicine. He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell based regenerative therapies. Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.
Other professional activities:
Founder, IntelliMedicine & RegenMed Systems
Inventor of the FDA approved MarrowMiner
Adviser to the X PRIZE Foundation (Life Sciences), helped conceive and design the Medical Tricorder XPRIZE, and is Bold Innovator for Cancer XPRIZE.
Adviser to Rock Health, Qualcomm Life, Nokia and several life sciences and Healthcare-IT startups
Bachelor of Arts in Biochemistry, Brown University
Medical Doctor, Stanford University School of Medicine
Residency: Harvard Combined Residency in Internal Medicine & Pediatrics
Fellowships: Stanford, Hematology/Oncology & Bone Marrow Transplantation
TEDxSF – The Future of Medicine, Where Can Technology Take Us?
Medicine’s Future? There’s an App for That, TEDTalk
Regenerative Medicine – Hype Hope and Reality, TEDMED Talk
Invents a Better Way to Harvest Bone Marrow, TEDTalk
The Empowered You: How Healthcare Is Evolving With Technology | TEDxBeaconStreetSalon
The pharmacy of the future? Personalized pills, 3D printed at home
Interview at CES2019 - Digital Health Live Studio #DHS19
2018 Virtual Medicine Conference
Medicine 2064 with Dr. Daniel Kraft
SU Global Summit 2019: Day 3
Future of Medicine
The Future of Medicine and Healthcare Comprehensive overview of what is in the lab today and what is coming to market in the next 2 to 10 years. The presentation will concentrate on breakthrough developments ranging from 3D printing to organ regeneration, from point-of-care lab-on-a-chip diagnostics to large-scale bioinformatics; from synthetic biology to new gene based therapies. All of these and more are discussed in the context of current explosions of digital information and distributed healthcare.
Medicine Track: Design in Healthcare
Design touches everything. From 3D printed artificial limbs to User Experience, design is an important aspect the defines customer experience
Medicine Track: Engaged & Empowered Patients
Patient Driven Healthcare: we’re in an era of access to information, which is empowering patients to be a key decision maker on the healthcare team
Medicine Track: Future of Intervention & Robotics
From Robotic Surgery, Bionic limbs and exoskeletons, Smart pills, and Implantable Devices, to targeted gene therapy, and ever shrinking and more capable devices, Nanomedicine.
Medicine Track: Future of Medical Practice
How convergent technology will impact the practice of medicine, new models of care from concierge to telemedicine.
Medicine Track: Information & Data Driven Health
The data explosion… from Electronic Medical Records, Quantified Self, Imaging & Diagnostics to Mobile & Internet Enabled Health
Medicine Track: Innovation & Entrepreneurship
Innovating mindset, design thinking, funding, opportunities and barriers (regulatory and otherwise) of biomedical innovation.
Medicine Track: Neuromedicine
Real time brain imaging, Brain computer interface (BCI), Cognitive Enhancement, Targeted neurointervention, Psychiatry and Behavioral Medicine.
Medicine Track: Personalized Medicine
Systems medicine & biology to the rapidly emerging world of Synthetic Biology, Diagnostics and DIY Biology
Medicine Track: Regenerative medicine
Stem cells & beyond, cellular alchemy to 3-D printing of organs and tissues.
The Future of Health & Medicine: Where can Technology Take Us?
Comprehensive overview of what is in the lab today and what is coming to market in the next 2 to 10 years. The presentation will concentrate on breakthrough developments ranging from 3D printing to organ regeneration, from point-of-care lab-on-a-chip diagnostics to large-scale bioinformatics; from synthetic biology to new gene based therapies. All of these and more are discussed in the context of current explosions of digital information and distributed healthcare.
See All Faculty